← SynDRA
LDN-193189
SynDRA canonical compound SYN0087399 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ACVR1 |
|---|
| Mechanism of action | Serine/threonine kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Serine/threonine kinase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACVR1B
- BMPR1A
- BMPR1B
- BMPR2
- HDAC6
- KDR
- PRKAB1
- TGFBR1
- TGFBR2
Cross-references
Synonyms
- LDN 193189
- W69H5YQU9O
- RefChem:1070007
- DTXCID3070044
- LDN193189
- MFCD17169988
- LDN193189 (GMP)
- DM-3189
- UNII-W69H5YQU9O
- DM 3189 hydrochloride
- LDN193189 free base
- LDN193189 free base?
- SCHEMBL456393
- orb1307060
- SCHEMBL29353046
- CHEBI:91387
- EX-A424
- HMS3743E21
- BDBM50262079
- DM3189
- HY-12071G
- s2618
- AKOS024464854
- CS-0669
- EX-8677
- FP43352
- SB19315
- SDCCGSBI-0654416.P001
- NCGC00249389-01
- NCGC00249389-15
- NCGC00249389-17
- NCGC00249389-21
- AC-31395
- AS-73735
- HY-12071
- SY016321
- CS-0615622
- cas:1062368-24-4;LDN193189
- BRD-K04853698-003-01-4
Look up LDN-193189 in the interactive SynDRA portal →